MicroPort NeuroScientific Corporation (HKG:2172)
12.76
+0.30 (2.41%)
Jan 21, 2026, 3:15 PM HKT
MicroPort NeuroScientific Revenue
MicroPort NeuroScientific had revenue of 382.93M CNY in the half year ending June 30, 2025, with 27.99% growth. This brings the company's revenue in the last twelve months to 736.47M, down -4.93% year-over-year. In the year 2024, MicroPort NeuroScientific had annual revenue of 761.76M with 14.44% growth.
Revenue (ttm)
736.47M CNY
Revenue Growth
-4.93%
P/S Ratio
8.89
Revenue / Employee
1.41M CNY
Employees
522
Market Cap
7.18B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 761.76M | 96.14M | 14.44% |
| Dec 31, 2023 | 665.62M | 118.27M | 21.61% |
| Dec 31, 2022 | 547.35M | 164.55M | 42.99% |
| Dec 31, 2021 | 382.80M | 160.88M | 72.49% |
| Dec 31, 2020 | 221.92M | 38.20M | 20.79% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| JD Health International | 71.34B |
| BeOne Medicines AG | 38.69B |
| Alibaba Health Information Technology | 36.09B |
| Sino Biopharmaceutical | 33.49B |
| CSPC Pharmaceutical Group | 28.65B |
| WuXi Biologics | 21.98B |
| Hansoh Pharmaceutical Group Company | 14.45B |
| Innovent Biologics | 12.52B |